[1] GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 2025;405(10481):813 − 38. https://doi.org/10.1016/S0140-6736(25)00355-1.
[2] Wang LM, Zhou B, Zhao ZP, Yang L, Zhang M, Jiang Y, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18. Lancet 2021;398(10294):53 − 63. https://doi.org/10.1016/S0140-6736(21)00798-4.
[3] Dong YH, Yuan CZ, Dang JJ, Song XL, Cheng G, Chen YJ, et al. Control of childhood obesity and implications for policy in China. Lancet Public Health 2024;9(12):e1125 − 35. https://doi.org/10.1016/S2468-2667(24)00263-9.
[4] Lam TK, Daschner P, Ishibe N, Wali A, Hall K, Czajkowski S, et al. Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. J Natl Cancer Inst 2024;116(10):1555 − 61. https://doi.org/10.1093/jnci/djae134.
[5] Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer — Viewpoint of the IARC working group. N Engl J Med 2016;375(8):794 − 8. https://doi.org/10.1056/NEJMsr1606602.
[6] Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371(9612):569 − 78. https://doi.org/10.1016/S0140-6736(08)60269-X.
[7] Liu C, Yuan YC, Guo MN, Xin Z, Chen GJ, Ding N, et al. Rising incidence of obesity-related cancers among younger adults in China: a population-based analysis (2007-2021). Med 2024;5(11):1402 − 12.e2. https://doi.org/10.1016/j.medj.2024.07.012.
[8] Singh A, Mayengbam SS, Yaduvanshi H, Wani MR, Bhat MK. Obesity programs macrophages to support cancer progression. Cancer Res 2022;82(23):4303 − 12. https://doi.org/10.1158/0008-5472.CAN-22-1257.
[9] National Health Commission of the People’s Republic of China. Implementation plan for the “Weight management year”. Chin Pract J Rural Doct 2024;31(8):1 − 2,4. https://doi.org/10.3969/j.issn.1672-7185.2024.08.001.
[10] Office of the National Health Commission, Office of the National Administration of Traditional Chinese Medicine. Notice on the establishment and management of healthy weight management clinics (Guowei Ban Yizheng Han [2025] No 113). 2025. https://www.nhc.gov.cn/yzygj/c100068/202504/52bcc453524149b884ddf6e2969d24d9.shtml. [2025-8-19]. (In Chinese).
[11] Lloyd-Jones DM, Hong YL, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010;121(4):586 − 613. https://doi.org/10.1161/CIRCULATIONAHA.109.192703.
[12] Birks S, Peeters A, Backholer K, O’Brien P, Brown W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev 2012;13(10):868 − 91. https://doi.org/10.1111/j.1467-789X.2012.01010.x.
[13] Liao CY, Sheffield KM, Hoog MM, Schapiro D, Keni R, Gathirua-Mwangi WG, et al. EPR24-109: intentional weight loss and associated cancer incidence among patients with overweight or obesity: a systematic literature review. J Natl Compr Canc Netw 2024;22(2.5):EPR24 − 109. https://doi.org/10.6004/jnccn.2023.7270.
[14] Yuan CZ, Dong YH, Chen H, Ma L, Jia LH, Luo JY, et al. Public health interventions against childhood obesity in China. Lancet Public Health 2024;9(12):e1115 − 24. https://doi.org/10.1016/S2468-2667(24)00245-7.
[15] Rivera-Izquierdo M, Pérez de Rojas J, Martínez-Ruiz V, Arrabal-Polo MÁ, Pérez-Gómez B, Jiménez-Moleón JJ. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients. Prostate Cancer Prostatic Dis 2022;25(3):411 − 21. https://doi.org/10.1038/s41391-021-00481-7.
[16] Hu CL, Zhang Q, Jin XH, Zhang L, Zhang YM, Zhu QK, et al. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage II and III colorectal cancer patients. Clin Nutr 2021;40(4):2410 − 9. https://doi.org/10.1016/j.clnu.2020.10.039.
[17] Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, et al. Association of locoregional control with high body mass index in women undergoing breast conservation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2016;96(1):65 − 71. https://doi.org/10.1016/j.ijrobp.2016.04.020.
[18] Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol 2011;29(34):4561 − 7. https://doi.org/10.1200/JCO.2011.37.1260.
[19] Chinese Nutrition Society Obesity Prevention and Control Section, Chinese Nutrition Society Clinical Nutrition Section, Chinese Preventive Medicine Association Behavioral Health Section, et al. Expert consensus on obesity prevention and treatment in China. Chin J Epidemiol 2022;43(5):609 − 26. https://doi.org/10.3760/cma.j.cn112338-20220402-00253.
[20] Cong FC, Jia CC, Li ZG. Study on the development path of integration of prevention and treatment in the process of Chinese modernization. Health Econ Res 2024;41(10):6 − 9. https://doi.org/10.14055/j.cnki.33-1056/f.2024.10.003.
[21] Gao P, Xia Q, Li YF. The specific methods analysis of health management in cancer prevention and control. Chin J Soc Med 2012;29(6):390 − 2. https://doi.org/10.3969/j.issn.1673-5625.2012.06.008.
[22] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective. 2018. https://www.wcrf.org/diet-activity-and-cancer/. [2025-7-10].